Litcius/Paper detail

National Trends in Glucagon-Like Peptide-1 Receptor Agonist Use in Adults Without Diabetes, 2018 to 2022

Cade Shadbolt, Jasmin Elkin, Chris Schilling, Xinyang Hua, Peter Choong, Michelle M. Dowsey

2025Annals of Internal Medicine8 citationsDOI

Topics & Concepts

MedicineAgonistDiabetes mellitusEndocrinologyGlucagon-like peptide 1 receptorInternal medicineGlucagon-like peptide-1GlucagonReceptorInsulinType 2 diabetesDiabetes Treatment and ManagementDiabetes Management and ResearchPharmacology and Obesity Treatment
National Trends in Glucagon-Like Peptide-1 Receptor Agonist Use in Adults Without Diabetes, 2018 to 2022 | Litcius